Glycotest Innovator Joins the Medical University of South Carolina as the New SmartState Endowed Chair of Proteomic Biomarkers
Glycotest Intellectual Property Portfolio Strengthened by Grant of Japanese Patent
Latest Investor Presentation
Dr. Timothy Block, President, Baruch S. Blumberg Institute and the Hepatitis B Foundation, in a video on the Glycotest Technology
Lawrence Cohen, CEO of Glycotest, presented at Net Scientific’s June 2016 Capital Markets Day.
Lawrence Cohen, CEO of Glycotest, will be presenting the company at the New York Venture Summit on July 21, 2016.
NetScientific portfolio company, Glycotest Inc., appoints world leading medical advisory board chaired by David Chernoff, M.D.
NetScientific appoints diagnostics leader Lawrence Cohen as CEO of Glycotest Inc.
NetScientific’s subsidiary, Glycotest Begins a New Research Collaboration with Oncimmune